ESSA Pharma Inc. - Common Shares, no par value per share (EPIX)
CUSIP: 29668H708
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Shares, no par value per share
- Shares outstanding
- 47,601,550
- Total 13F shares
- 37,773,975
- Share change
- +577,572
- Total reported value
- $118,994,687
- Price per share
- $3.15
- Number of holders
- 55
- Value change
- -$275,773
- Number of buys
- 17
- Number of sells
- 37
Quarterly Holders Quick Answers
What is CUSIP 29668H708?
CUSIP 29668H708 identifies EPIX - ESSA Pharma Inc. - Common Shares, no par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29668H708:
Top shareholders of EPIX - ESSA Pharma Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q2 2022
As of 30 Jun 2022,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,773,975 shares.
The largest 10 holders included
Bellevue Group AG, Soleus Capital Management, L.P., BVF INC/IL, MORGAN STANLEY, EVENTIDE ASSET MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, RTW INVESTMENTS, LP, Avidity Partners Management LP, Blackstone Inc., and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
55
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
66
Q2 2022 holders
55
Holder diff
-11
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.